Lobbying

Accumulus Synergy's latest lobbying report covers Q2 2026, at $20K. The four quarters Q4 2025–Q3 2026 total $60K. Its first report covers Q1 2025; the issues it reports most are Health Issues and Computer Industry.

Accumulus Synergy

Latest quarter
No record
Q3 2026 · 0 reports
Last 12 months
$60K
Last 4 quarters
vs last quarter
−100.0%
Q3 2026 against the quarter before
First report
Q1 2025
The first quarter a report named it

Lobbying by quarter

Accumulus Synergy lobbying by quarter
Accumulus Synergy lobbying by quarter
QuarterAmountReports
Q1 2025$90K1
Q2 2025$90K1
Q3 2025$60K1
Q4 2025$20K2
Q1 2026$20K2
Q2 2026$20K2
Q3 2026$00

By issue

  • Health issues$250K · 6 reports
  • Computer industry$10K · 2 reports
  • Medical research and clinical labs$10K · 2 reports
  • Science and technology$10K · 2 reports

An issue's amount splits each report's amount equally over the issues the report lists.

Who was lobbied

  • HOUSE OF REPRESENTATIVES4 reports
  • SENATE4 reports

Firms it paid

Firm
BGR Government Affairs$240K6 quarters
Esham Strategies$60K3 quarters

Former officials lobbying for it

Former position
JOHN STONECounsel, House E&C Cmte, Oversight Subcommittee; Senior Counsel, House E&C Cmte, Health Subcommittee; Intern, House E&CQ4 2025
REMY LEIGH BRIM MASONSenior FDA Policy Advisor to Senate HELP Committee Ranking Member Patty Murray; Senior Health Policy Advisor Sen. Elizabeth Warren; Intern to Rep. Allyson SchwartzQ4 2025
SCOTT EISNERN/AQ4 2025

Lobbying reports

Filed by
07/16for Q2BGR Government AffairsUnder $5,000
07/02for Q2Esham Strategies$20K
04/20for Q1BGR Government AffairsUnder $5,000
04/01for Q1Esham Strategies$20K
01/20for Q4 2025BGR Government AffairsUnder $5,000
01/09for Q4 2025Esham Strategies$20K
25/10/20for Q3 2025BGR Government Affairs$60K
25/10/17for Q4 2025Esham StrategiesUnder $5,000
25/07/21for Q2 2025BGR Government Affairs$90K
25/04/21for Q1 2025BGR Government Affairs$90K
25/04/10for Q1 2025BGR Government AffairsUnder $5,000